Cartesian Therapeutics Statistics
Total Valuation
RNAC has a market cap or net worth of $376.69 million. The enterprise value is $178.06 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, before market open.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RNAC has 25.91 million shares outstanding. The number of shares has increased by 235.72% in one year.
Current Share Class | 25.91M |
Shares Outstanding | 25.91M |
Shares Change (YoY) | +235.72% |
Shares Change (QoQ) | +18.40% |
Owned by Insiders (%) | 57.96% |
Owned by Institutions (%) | 27.55% |
Float | 9.46M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.46 |
Forward PS | 103.41 |
PB Ratio | -55.38 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 4.58 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.43
Current Ratio | 9.43 |
Quick Ratio | 9.29 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -6.00% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -8.62% |
Revenue Per Employee | $589,591 |
Profits Per Employee | -$1.17M |
Employee Count | 66 |
Asset Turnover | 0.11 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, RNAC has paid $287,000 in taxes.
Income Tax | 287,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.61% in the last 52 weeks. The beta is 0.83, so RNAC's price volatility has been lower than the market average.
Beta (5Y) | 0.83 |
52-Week Price Change | -26.61% |
50-Day Moving Average | 18.02 |
200-Day Moving Average | 18.45 |
Relative Strength Index (RSI) | 33.20 |
Average Volume (20 Days) | 98,362 |
Short Selling Information
The latest short interest is 2.03 million, so 7.84% of the outstanding shares have been sold short.
Short Interest | 2.03M |
Short Previous Month | 2.10M |
Short % of Shares Out | 7.84% |
Short % of Float | 21.46% |
Short Ratio (days to cover) | 25.39 |
Income Statement
In the last 12 months, RNAC had revenue of $38.91 million and -$77.42 million in losses. Loss per share was -$4.49.
Revenue | 38.91M |
Gross Profit | -5.99M |
Operating Income | -35.52M |
Pretax Income | -248.65M |
Net Income | -77.42M |
EBITDA | -34.37M |
EBIT | -35.52M |
Loss Per Share | -$4.49 |
Full Income Statement Balance Sheet
The company has $212.61 million in cash and $13.98 million in debt, giving a net cash position of $198.63 million or $7.67 per share.
Cash & Cash Equivalents | 212.61M |
Total Debt | 13.98M |
Net Cash | 198.63M |
Net Cash Per Share | $7.67 |
Equity (Book Value) | -6.80M |
Book Value Per Share | -0.26 |
Working Capital | 193.65M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$23.67 million and capital expenditures -$9.09 million, giving a free cash flow of -$32.77 million.
Operating Cash Flow | -23.67M |
Capital Expenditures | -9.09M |
Free Cash Flow | -32.77M |
FCF Per Share | -$1.26 |
Full Cash Flow Statement Margins
Gross margin is -15.40%, with operating and profit margins of -91.28% and -198.97%.
Gross Margin | -15.40% |
Operating Margin | -91.28% |
Pretax Margin | -198.23% |
Profit Margin | -198.97% |
EBITDA Margin | -88.32% |
EBIT Margin | -91.28% |
FCF Margin | n/a |
Dividends & Yields
RNAC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -235.72% |
Shareholder Yield | n/a |
Earnings Yield | -20.55% |
FCF Yield | -8.70% |
Analyst Forecast
The average price target for RNAC is $40.83, which is 180.81% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $40.83 |
Price Target Difference | 180.81% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 44.24% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.0333333:1.
Last Split Date | Apr 5, 2024 |
Split Type | Reverse |
Split Ratio | 0.0333333:1 |
Scores
RNAC has an Altman Z-Score of -1.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.42 |
Piotroski F-Score | 3 |